Belvedere Trading LLC Veru Inc. Put Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$1.16 - $6.41 $115 - $641	100 Added 1.82%	5,600 $6,000
Q4 2022 Feb 14, 2023	SELL	$4.78 - $15.01 $226,094 - $709,973	-47,300 Reduced 89.58%	5,500 $29,000
Q3 2022 Oct 26, 2022	SELL	$10.22 - $23.7 $166,586 - $386,310	-16,300 Reduced 23.59%	52,800 $614,000
Q2 2022 Jul 21, 2022	BUY	$4.35 - $15.85 $69,165 - $252,015	15,900 Added 29.89%	69,100 $1.16 Million
Q1 2022 Apr 20, 2022	BUY	$4.55 - $6.41 $242,060 - $341,012	53,200 New	53,200 $672,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.